The market for pharmaceutical water is propelled by the increasing need for premium-quality pharmaceutical water in various uses, including parenteral solutions, intravenous fluids, and active pharmaceutical ingredients (APIs). Tight regulations...
The pharmaceutical sector, projected to nearly double to about USD 130 billion by 2030, aims to leverage favorable policies, demographics, and digital expertise to position India as a key player in enhancing global health for everyone...
In the pharmaceutical industry, a revenue growth of 9-11 percent is expected for FY25 and FY26, supported by digital transformation, increased internet availability, and broader expansion in Tier-I and Tier-II cities. The top local brokerage has...
The Precision Medicine Software market is fueled by the rising occurrence of chronic illnesses, progress in genomics, and heightened consumer interest in tailored healthcare solutions. The increasing prevalence of cancer, heart diseases, and...
The expansion of the global pharmaceutical eCommerce market is fueled by the swift embrace of digital platforms within the healthcare sector, with projections indicating a compound annual growth rate (CAGR) of 14.4% from 2024 to 2034. The market...
Verismo Therapeutics and HLB Innovation will expedite the clinical advancement of SynKIR-110 and SynKIR-310 for patients with solid tumors and blood cancers, respectively, reinforcing the shared goal of Verismo and HLB Group to promote their...
The growth of the pharmaceutical excipient market is driven by the rising use of advanced drug delivery systems, biologics, and drug formulations focused on patient needs. The market is projected to increase from US$ 972.9 million in 2024 to US$...
The expansion of the pharmaceutical processing seals market is influenced by multiple factors, such as the rising intricacy of drug production, strict regulatory standards, and developments in drug delivery systems. A primary factor is the...
Pfizer Inc revealed that the US Food and Drug Administration (FDA) has authorized BRAFTOVI (encorafenib) alongside cetuximab (sold as ERBITUX) and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) for treating patients with metastatic...
In the financial year 2024, India's pharmaceutical exports totaled Rs 2.3 lakh crore, an increase from Rs 1.1 lakh crore in FY14. Pharma exports increased by 8.36% from Rs 17,750 crore in July 2023 to Rs 18,670 crore in July 2024. The government...